Drugs / Fecal microbiota suspension
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT02889627 | Nov 2016 → Oct 2025 | epilepsy | The Second Hospital of Nanjing Medical University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fecal microbiota suspension | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02889627 ↗ |
| Route | Other | “The prepared microbiota suspension was infused into the participates' mid-gut or lower gut.” NCT02889627 ↗ |